Background: Phosphoglyceride crystal deposition disease (PGDD) is characterized by phosphoglyceride crystal deposition that simulates neoplasia in soft tissue scars or bone. Reports of PGDDs are rare. Here, we present the case of a patient with PGDD in the abdominal wall. Case presentation: A 57-year-old Japanese man with worsening right lower abdominal pain had no significant family or occupational history. Laboratory data showed elevated inflammatory markers with a white blood cell count of 14,400 × 10
Background
Phosphoglyceride crystal deposition disease (PGDD) is characterized by phosphoglyceride crystal deposition that simulates neoplasia in soft tissue scars or bone. The condition is rarely encountered in the clinical setting and is sometimes strongly suspected of being a malignant tumor based on clinical and radiographic findings. The lesions often occur over injection sites or surgical scars, such as the periumbilical area or upper arm, suggesting a possible relationship with these procedures.
In this report, we describe a case of PGDD in the abdominal wall, which was resected surgically after being initially diagnosed as a malignant tumor.
Case presentation
A 57-year-old Japanese man was referred to our hospital because of increasing right lower abdominal pain. He had a history of appendectomy at the age of 17 years with no significant family or occupational history.
On initial examination, an abdominal wall tumor (largest dimension, approximately 10 cm in diameter) was detected using transabdominal ultrasound (Fig. 1) . Laboratory data revealed elevated inflammatory markers (WBC = 14,400 × 10 9 /L, CRP = 11.8 mg/L); major tumor markers (carcinoembryonic antigen, CA19-9, and soluble IL-2 receptor) were within normal limits. Helical computed tomography (CT) also revealed a solid mass (largest dimension, 10 cm in diameter) in the abdominal wall (Fig. 2) . Magnetic resonance imaging showed a mass that exhibited low intensity on T2-weighted images, slightly high intensity on diffusion-weighted images, and gradual reinforcement on dynamic study (Fig. 3) . Positron emission tomography-CT revealed fluorodeoxyglucose accumulation in the mass only (SUVmax, 41) (Fig. 4) . Because clinical and radiographic findings suggested malignant lymphoma, undifferentiated sarcoma, or liposarcoma, he underwent exploratory laparotomy and treatment.
Intraoperative findings at laparotomy were an elastic, hard, milky-whitish mass with a rough surface and capillary growth in the right lower quadrant (Fig. 5) . On inspection and palpation, a malignant tumor was strongly suspected. No other tumor suspicious of a primary lesion was found in the intraabdominal organs, including the gastrointestinal tract. The mass was completely removed, and the surgical margin secured. The total weight of the mass was 120 g. No complications were observed during the perioperative period, and the patient was discharged on postoperative day 7. Pathologic examination revealed that these masses were foreign-body granulomas consisting of string-like crystals and a foreign-body giant cell (Fig. 6a, b) . Immunohistological staining using anti-CD68 antibody (clone KP1) against the CD68 antigen, which is a known macrophage surface marker, was positive in cells surrounding phosphoglyceride crystals (Fig. 6c) .
The patient underwent regular follow-up abdominal ultrasound examination and CT postoperatively. As of 3 years after the procedure, no signs of recurrence have been detected. PGDD is a rare disease characterized by deposition of phosphoglyceride crystals, often simulating neoplasm in a scar of soft tissue or bone. It can sometimes form a large mass and be misdiagnosed as a malignant tumor.
Little is known about its etiology and pathogenesis. This deposition disease is apparently triggered by injury and subsequent macrophage aggregation, with a histological picture of deposited crystal radiating from the cell membranes of epithelioid cells. The macrophages themselves may contribute to the formation of a nidus for the crystals. One hypothesis is that localized disturbance of phosphoglyceride metabolism within the macrophages may be initiated by local inflammation, leading to progressive amplification of macrophage infiltration and crystal deposition.
To our knowledge, only 10 cases of PGDD have been reported previously, including our case. The available clinical information on these cases is summarized in Table 1 [1] [2] [3] [4] [5] [6] [7] . The mean age of patients is 57 (range, 37-76) years. There appears to be no gender predilection. No congenital abnormalities or family history of metabolic disorders have been found. Deposition was characteristically noted at intramuscular injection sites or postoperative sites like the gluteal muscles and the deltoid, abdominal wall soft tissue, scapula, spine, myocardium, and pelvic soft tissue. The size of the tumors reported is highly variable, from 3.5 cm to the size of an infant's head, but in general it is a relatively large tumor with a mean size of 8.9 cm. The time from the initial invasion to confirmation of the tumor was at least 20 years and was 45 years in the longest case. About half of the cases had multiple lesions. In most cases, excisional surgery was performed due to local tumor formation without apparent symptoms of inflammation. Tumors that occurred at postoperative sites were suspected to be true malignant neoplasms or recurrent tumors. In one case, intraoperative rapid pathological diagnosis revealed PGDD, so complete resection was not performed and the patient was observed clinically.
No specific markers exist for PGDD, and differentiating this disease from malignant tumors without pathological examination is difficult. We considered needle biopsy in the present case but decided against it given the risk of needle tract seeding if malignant.
In the present case, exploratory laparotomy, not laparoscopic surgery, was performed for a suspected huge malignant tumor of the abdominal wall, based on radiographic examination. Our patient had a history of Postoperative follow-up has not revealed any findings suspicious of recurrence in our case. However, there are reports in the literature of recurrence at 4 years after surgery [7] . Few studies have reported on the process of crystallization and deposition of phosphoglycerides and so the mechanism remains unclear. Local injection of a bovine-derived medication has been suggested as causative, yet that alone does not explain PGDD, including the present case. In reviewing previous reports, a few cases suggest that during the process of phosphoglyceride metabolism, a locally invasive procedure increases macrophage activation and leads to phosphoglyceride 
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